azd6738
Small moleculeexperimental
Clinical trial activity
20 trials · 21 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
12
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT01955668)
Timeline
Indications
Studied for
- Bile Duct Neoplasms · Phase 2
- Breast Neoplasms · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Renal Cell · Phase 2
- Carcinoma, Transitional Cell · Phase 2
- Drug-Related Side Effects and Adverse Reactions · Phase 2
- Endometrial Neoplasms · Phase 2
- Homologous Recombination · Phase 2
- Leukemia · Phase 1
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 1
- Leukemia, Prolymphocytic · Phase 1
- Lymphoma, B-Cell · Phase 1
- Lymphoma, Large B-Cell, Diffuse · Phase 1
- Lymphoma, Large-Cell, Immunoblastic · Phase 1
- Lymphoma, Non-Hodgkin · Phase 1
- Melanoma · Phase 2
- Myelodysplastic Syndromes · Phase 1
- Neoplasms · Phase 2
- Pancreatic Neoplasms · Phase 2
- Prostatic Neoplasms · Phase 2
- Prostatic Neoplasms, Castration-Resistant · Phase 2
- Small Cell Lung Carcinoma · Phase 2
- Squamous Cell Carcinoma of Head and Neck · Phase 1
- Stomach Neoplasms · Phase 2
Mechanism of action
- Serine-protein kinase ATRINHIBITOR
ATR inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545178 ↗
Also known as
- azd6738
- azd6738
- azd-6738
- azd-6738
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06754761 | Phase 1 | Jan 17, 2025 | AstraZeneca |
| NCT04298021 | Phase 2 | Apr 1, 2020 | Seoul National University |
| NCT04298008 | Phase 2 | Apr 1, 2020 | Seoul National University |
| NCT04065269 | Phase 2 | Sep 30, 2019 | AstraZeneca, Cancer Research UK, Royal Marsden Hospital NHS Trust, University of London |
| NCT03780608 | Phase 2 | Sep 1, 2019 | Sungkyunkwan University |
| NCT03770429 | Phase 1 | Jul 31, 2019 | AstraZeneca, Harvard University |
| NCT03787680 | Phase 2 | Jun 30, 2019 | University of Michigan |
| NCT03669601 | Phase 1 | Mar 31, 2019 | AstraZeneca, University of Cambridge |
| NCT03833440 | Phase 2 | Mar 31, 2019 | Aix-University of Marseille |
| NCT03740893 | Phase 2 | Feb 28, 2019 | AstraZeneca, University of London |
| NCT03682289 | Phase 2 | Oct 1, 2018 | University of California, San Francisco |
| NCT03527147 | Phase 1 | Jun 30, 2018 | Acerta Pharma, AstraZeneca, Tennessee Oncology, PLLC |
| NCT03428607 | Phase 2 | Feb 28, 2018 | Sungkyunkwan University |
| NCT03330847 | Phase 2 | Feb 21, 2018 | AstraZeneca, Guy's and St Thomas Hospital |
| NCT03334617 | Phase 2 | Dec 18, 2017 | AstraZeneca, University of Texas at Houston |
| NCT03022409 | Phase 1 | Mar 1, 2017 | AstraZeneca, Institut Gustave Roussy, The Christie NHS Foundation Trust, University of Pittsburgh |
| NCT02630199 | Phase 1 | Dec 1, 2015 | Sungkyunkwan University |
| NCT02264678 | Phase 1/Phase 2 (Phase 2) | Oct 21, 2014 | AstraZeneca |
| NCT02223923 | Phase 1 | Jul 1, 2014 | AstraZeneca, Cancer Research UK, RM/ICR Biomedical Research Centre, Royal Marsden Hospital NHS Trust, University of London |
| NCT01955668 | Phase 1 | Nov 1, 2013 | AstraZeneca, CLL Consortium, University of California, San Diego |
Showing 20 of 20 trials
Page 1 / 1
Organizations
Research & Development (21)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 12 | 6 | 2 | 2013 |
| Sungkyunkwan University | Academic/Hospital | 3 | 3 | 2 | 2015 |
| University of London | Academic/Hospital | 3 | 2 | 2 | 2014 |
| Cancer Research UK | Academic/Hospital | 2 | 0 | 2 | 2014 |
| Royal Marsden Hospital NHS Trust | Academic/Hospital | 2 | 1 | 2 | 2014 |
| Seoul National University | Academic/Hospital | 2 | 2 | 1 | 2020 |
| Acerta Pharma | For profit | 1 | 1 | 1 | 2018 |
| Aix-University of Marseille | Academic/Hospital | 1 | 1 | 1 | 2019 |
| CLL Consortium | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Guy's and St Thomas Hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Institut Gustave Roussy | Academic/Hospital | 1 | 0 | 1 | 2017 |
| RM/ICR Biomedical Research Centre | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Tennessee Oncology, PLLC | Academic/Hospital | 1 | 0 | 1 | 2018 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Cambridge | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2017 |
21 organizations
Page 1 / 2